CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Accounts Payable
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Accounts Payable of -$1.43 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2026-07-31 was -$1.43M, a 446.72% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2026-04-30 was $1.27M.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2026-01-31 was -$437.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2025-10-31 was $1.31M.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2026 was $2.56M.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2025 was -$1.75M, a 476.13% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2024 was $465.00K, a 81.14% decline from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2023 was $2.46M, a 153.08% increase from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$1.43M 10-Q · filed 2026-09-11 | -$152.00K derived: sum of 2 quarters · filed 2026-09-11 | -$589.00K derived: sum of 3 quarters · filed 2026-09-11 | $722.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2026-04-30 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $836.00K derived: sum of 2 quarters · filed 2026-07-27 | $2.15M derived: sum of 3 quarters · filed 2026-07-27 | $2.56M 10-K · filed 2026-07-27 |
| 2026-01-31 | -$437.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | $874.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.28M 10-Q · filed 2026-03-12 | $671.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-10-31 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $1.72M 10-Q · filed 2025-12-15 | $1.11M derived: sum of 3 quarters · filed 2026-09-11 | $920.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-07-31 | $411.00K 10-Q · filed 2026-09-11 | -$203.00K derived: sum of 2 quarters · filed 2026-09-11 | -$391.00K derived: sum of 3 quarters · filed 2026-09-11 | -$773.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-04-30 | -$614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | -$802.00K derived: sum of 2 quarters · filed 2026-07-27 | -$1.18M derived: sum of 3 quarters · filed 2026-07-27 | -$1.75M 10-K · filed 2026-07-27 |
| 2025-01-31 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | -$570.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.14M 10-Q · filed 2026-03-12 | -$92.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | -$382.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | -$947.00K 10-Q · filed 2025-12-15 | $96.00K derived: sum of 3 quarters · filed 2025-12-15 | $318.00K derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | -$565.00K 10-Q · filed 2025-09-15 | $478.00K derived: sum of 2 quarters · filed 2025-09-15 | $700.00K derived: sum of 3 quarters · filed 2025-09-15 | -$524.00K derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $1.26M derived: sum of 2 quarters · filed 2025-07-23 | $41.00K derived: sum of 3 quarters · filed 2025-07-23 | $465.00K 10-K · filed 2025-07-23 |
| 2024-01-31 | $222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | -$1.00M derived: sum of 2 quarters · filed 2025-03-17 | -$578.00K 10-Q · filed 2025-03-17 | $457.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | -$800.00K 10-Q · filed 2024-12-16 | $235.00K derived: sum of 3 quarters · filed 2024-12-16 | -$72.00K derived: sum of 4 quarters · filed 2024-12-16 |
| 2023-07-31 | $424.00K 10-Q · filed 2024-09-13 | $1.46M derived: sum of 2 quarters · filed 2024-09-13 | $1.15M derived: sum of 3 quarters · filed 2024-09-13 | $3.22M derived: sum of 4 quarters · filed 2024-09-13 |
| 2023-04-30 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | $728.00K derived: sum of 2 quarters · filed 2024-07-19 | $2.80M derived: sum of 3 quarters · filed 2024-07-19 | $2.46M 10-K · filed 2024-07-19 |
| 2023-01-31 | -$307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15 | $1.76M derived: sum of 2 quarters · filed 2024-03-15 | $1.43M 10-Q · filed 2024-03-15 | $632.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-10-31 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-13 | $1.74M 10-Q · filed 2023-12-13 | $939.00K derived: sum of 3 quarters · filed 2023-12-13 | $1.21M derived: sum of 4 quarters · filed 2023-12-13 |
| 2022-07-31 | -$331.00K 10-Q · filed 2023-09-13 | -$1.13M derived: sum of 2 quarters · filed 2023-09-13 | -$863.00K derived: sum of 3 quarters · filed 2023-09-13 | -$729.00K derived: sum of 4 quarters · filed 2023-09-13 |
| 2022-04-30 | -$798.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | -$532.00K derived: sum of 2 quarters · filed 2023-07-24 | -$398.00K derived: sum of 3 quarters · filed 2023-07-24 | $974.00K 10-K · filed 2023-07-24 |
| 2022-01-31 | $266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $400.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.77M 10-Q · filed 2023-03-16 | $1.92M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $1.51M 10-Q · filed 2022-12-13 | $1.66M derived: sum of 3 quarters · filed 2022-12-13 | -$308.00K derived: sum of 4 quarters · filed 2022-12-13 |
| 2021-07-31 | $1.37M 10-Q · filed 2022-09-12 | $1.52M derived: sum of 2 quarters · filed 2022-09-12 | -$442.00K derived: sum of 3 quarters · filed 2022-09-12 | $591.00K derived: sum of 4 quarters · filed 2022-09-12 |
| 2021-04-30 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | -$1.81M derived: sum of 2 quarters · filed 2022-07-22 | -$781.00K derived: sum of 3 quarters · filed 2022-07-22 | -$1.25M 10-K · filed 2022-07-22 |
| 2021-01-31 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | -$930.00K derived: sum of 2 quarters · filed 2022-03-15 | -$1.40M 10-Q · filed 2022-03-15 | -$149.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13 | $568.00K 10-Q · filed 2021-12-13 | $1.81M derived: sum of 3 quarters · filed 2021-12-13 | $1.24M derived: sum of 4 quarters · filed 2021-12-13 |
| 2020-07-31 | -$465.00K 10-Q · filed 2021-09-13 | $781.00K derived: sum of 2 quarters · filed 2021-09-13 | $209.00K derived: sum of 3 quarters · filed 2021-09-13 | -$50.00K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $674.00K derived: sum of 2 quarters · filed 2021-07-26 | $415.00K derived: sum of 3 quarters · filed 2021-07-26 | $333.00K 10-K · filed 2021-07-26 |
| 2020-01-31 | -$572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | -$831.00K derived: sum of 2 quarters · filed 2021-03-15 | -$913.00K 10-Q · filed 2021-03-15 | -$214.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-10-31 | -$259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-14 | -$341.00K 10-Q · filed 2020-12-14 | $358.00K derived: sum of 3 quarters · filed 2020-12-14 | $453.00K derived: sum of 4 quarters · filed 2020-12-14 |
| 2019-07-31 | -$82.00K 10-Q · filed 2020-09-14 | $617.00K derived: sum of 2 quarters · filed 2020-09-14 | $712.00K derived: sum of 3 quarters · filed 2020-09-14 | $614.00K derived: sum of 4 quarters · filed 2020-09-14 |
| 2019-04-30 | $699.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $794.00K derived: sum of 2 quarters · filed 2020-07-28 | $696.00K derived: sum of 3 quarters · filed 2020-07-28 | $653.00K 10-K · filed 2020-07-28 |
| 2019-01-31 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | -$3.00K derived: sum of 2 quarters · filed 2020-03-16 | -$46.00K 10-Q · filed 2020-03-16 | $131.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-10-31 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | -$141.00K 10-Q · filed 2019-12-16 | $36.00K derived: sum of 3 quarters · filed 2019-12-16 | $463.00K derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-07-31 | -$43.00K 10-Q · filed 2019-09-16 | $134.00K derived: sum of 2 quarters · filed 2019-09-16 | $561.00K derived: sum of 3 quarters · filed 2019-09-16 | $378.00K derived: sum of 4 quarters · filed 2019-09-16 |
| 2018-04-30 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $604.00K derived: sum of 2 quarters · filed 2019-07-29 | $421.00K derived: sum of 3 quarters · filed 2019-07-29 | $301.00K 10-K · filed 2019-07-29 |
| 2018-01-31 | $427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $244.00K derived: sum of 2 quarters · filed 2019-03-18 | $124.00K 10-Q · filed 2019-03-18 | $653.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-10-31 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | -$303.00K 10-Q · filed 2018-12-17 | $226.00K derived: sum of 3 quarters · filed 2018-12-17 | $398.00K derived: sum of 4 quarters · filed 2018-12-17 |
| 2017-07-31 | -$120.00K 10-Q · filed 2018-09-14 | $409.00K derived: sum of 2 quarters · filed 2018-09-14 | $581.00K derived: sum of 3 quarters · filed 2018-09-14 | $224.00K derived: sum of 4 quarters · filed 2018-09-14 |
| 2017-04-30 | $529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $701.00K derived: sum of 2 quarters · filed 2018-07-30 | $344.00K derived: sum of 3 quarters · filed 2018-07-30 | -$43.00K 10-K · filed 2018-07-30 |
| 2017-01-31 | $172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | -$185.00K derived: sum of 2 quarters · filed 2018-03-19 | -$572.00K 10-Q · filed 2018-03-19 | -$191.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | -$357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | -$744.00K 10-Q · filed 2017-12-15 | -$363.00K derived: sum of 3 quarters · filed 2017-12-15 | -$186.00K derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | -$387.00K 10-Q · filed 2017-09-14 | -$6.00K derived: sum of 2 quarters · filed 2017-09-14 | $171.00K derived: sum of 3 quarters · filed 2017-09-14 | $73.00K derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $558.00K derived: sum of 2 quarters · filed 2017-07-28 | $460.00K derived: sum of 3 quarters · filed 2017-07-28 | $482.00K 10-K · filed 2017-07-28 |
| 2016-01-31 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $79.00K derived: sum of 2 quarters · filed 2017-03-17 | $101.00K 10-Q · filed 2017-03-17 | $153.00K derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | -$76.00K 10-Q · filed 2016-12-14 | -$24.00K derived: sum of 3 quarters · filed 2016-12-14 | -$294.00K derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | $22.00K 10-Q · filed 2016-09-14 | $74.00K derived: sum of 2 quarters · filed 2016-09-14 | -$196.00K derived: sum of 3 quarters · filed 2016-09-14 | $108.00K derived: sum of 4 quarters · filed 2016-09-14 |
| 2015-04-30 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$218.00K derived: sum of 2 quarters · filed 2016-07-29 | $86.00K derived: sum of 3 quarters · filed 2016-07-29 | $433.00K 10-K · filed 2016-07-29 |
| 2015-01-31 | -$270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | $34.00K derived: sum of 2 quarters · filed 2016-03-16 | $381.00K 10-Q · filed 2016-03-16 | $424.00K derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | $304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | $651.00K 10-Q · filed 2015-12-15 | $694.00K derived: sum of 3 quarters · filed 2015-12-15 | $648.00K derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | $347.00K 10-Q · filed 2015-09-11 | $390.00K derived: sum of 2 quarters · filed 2015-09-11 | $344.00K derived: sum of 3 quarters · filed 2015-09-11 | $351.00K derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$3.00K derived: sum of 2 quarters · filed 2015-07-29 | $4.00K derived: sum of 3 quarters · filed 2015-07-29 | -$223.00K 10-K · filed 2015-07-29 |
| 2014-01-31 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$39.00K derived: sum of 2 quarters · filed 2015-03-17 | -$266.00K 10-Q · filed 2015-03-17 | -$164.00K derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$220.00K 10-Q · filed 2014-12-15 | -$118.00K derived: sum of 3 quarters · filed 2014-12-15 | -$225.00K derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | -$227.00K 10-Q · filed 2014-09-12 | -$125.00K derived: sum of 2 quarters · filed 2014-09-12 | -$232.00K derived: sum of 3 quarters · filed 2014-09-12 | -$314.00K derived: sum of 4 quarters · filed 2014-09-12 |
| 2013-04-30 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | -$5.00K derived: sum of 2 quarters · filed 2014-07-28 | -$87.00K derived: sum of 3 quarters · filed 2014-07-28 | -$472.00K 10-K · filed 2014-07-28 |
| 2013-01-31 | -$107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | -$189.00K derived: sum of 2 quarters · filed 2014-03-14 | -$574.00K 10-Q · filed 2014-03-14 | -$521.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-10-31 | -$82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-13 | -$467.00K 10-Q · filed 2013-12-13 | -$414.00K derived: sum of 3 quarters · filed 2013-12-13 | -$85.00K derived: sum of 4 quarters · filed 2013-12-13 |
| 2012-07-31 | -$385.00K 10-Q · filed 2013-09-13 | -$332.00K derived: sum of 2 quarters · filed 2013-09-13 | -$3.00K derived: sum of 3 quarters · filed 2013-09-13 | -$207.00K derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-04-30 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | $382.00K derived: sum of 2 quarters · filed 2013-07-26 | $178.00K derived: sum of 3 quarters · filed 2013-07-26 | $96.00K 10-K · filed 2013-07-26 |
| 2012-01-31 | $329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | $125.00K derived: sum of 2 quarters · filed 2013-03-13 | $43.00K 10-Q · filed 2013-03-13 | -$460.00K derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | -$204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | -$286.00K 10-Q · filed 2012-12-13 | -$789.00K derived: sum of 3 quarters · filed 2012-12-13 | -$88.00K derived: sum of 4 quarters · filed 2012-12-13 |
| 2011-07-31 | -$82.00K 10-Q · filed 2012-09-12 | -$585.00K derived: sum of 2 quarters · filed 2012-09-12 | $116.00K derived: sum of 3 quarters · filed 2012-09-12 | $389.00K derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | -$503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $198.00K derived: sum of 2 quarters · filed 2012-07-18 | $471.00K derived: sum of 3 quarters · filed 2012-07-18 | $636.00K 10-K · filed 2012-07-18 |
| 2011-01-31 | $701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $974.00K derived: sum of 2 quarters · filed 2012-03-14 | $1.14M 10-Q · filed 2012-03-14 | |
| 2010-10-31 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14 | $438.00K 10-Q · filed 2011-12-14 | ||
| 2010-07-31 | $165.00K 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |